A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...
Investigators conducted a post-hoc analysis to determine the effect of race, socioeconomic factors, and clinicopathologic features on clinical outcomes in the ECOG-ACRIN EA1131 trial ...
The BRCA founder outreach study: Initial results of a digital health model. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.
ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences ® (Caris) announced today a multi-year research collaboration wherein Caris is pairing its highly sophisticated and comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results